Tecan Group
Providing laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics.
Launch date
Employees
Market cap
AUD5.1b
Enterprise valuation
AUD5.0b (Public information from Sep 2024)
Share price
CHF281.20001 TECN.SW
Zurich Canton of Zürich (HQ)
Financials
Estimates*
CHF | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 731m | 947m | 1.1b | 1.1b | 1.0b | 1.1b | 1.2b |
% growth | 15 % | 30 % | 21 % | (6 %) | (6 %) | 8 % | 8 % |
EBITDA | 153m | 207m | 214m | 201m | 184m | 221m | 246m |
% EBITDA margin | 21 % | 22 % | 19 % | 19 % | 18 % | 20 % | 21 % |
Profit | 104m | 122m | 121m | 132m | 96.4m | 128m | 146m |
% profit margin | 14 % | 13 % | 11 % | 12 % | 9 % | 12 % | 12 % |
EV / revenue | 6.5x | 7.5x | 4.5x | 4.0x | 3.5x | 3.1x | 2.8x |
EV / EBITDA | 30.8x | 34.0x | 24.1x | 21.2x | 19.1x | 15.5x | 13.6x |
R&D budget | 62.0m | 71.9m | 77.9m | 69.7m | - | - | - |
R&D % of revenue | 8 % | 8 % | 7 % | 6 % | - | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
Total Funding | - |
Related Content
Recent News about Tecan Group
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Tecan Group
EditACQUISITION by Waters Corporation Jan 2020
ACQUISITION by Tecan Group Aug 2016
ACQUISITION by Tecan Group Jul 2014
ACQUISITION by Tecan Group Oct 2015